Santé invests in early-stage life science and healthcare ventures to build valuable, enduring companies. We evaluate the following criteria when considering potential investment opportunities:
- Exceptional Entrepreneurs and Executives.
Uncompromising integrity; proven track record; relevant domain experience; complementary skill sets and diverse perspectives; intellectual honesty; ambition and energy.
- Product or Service.
Innovative and compelling value proposition or potential breakthrough improvement in clinical outcomes, healthcare efficiency or access; clear regulatory and reimbursement pathways.
- Market and Customers.
Large and/or rapidly growing market; playing into a technical or regulatory dislocation; clear evidence of customer adoption; efficient sales cycle or distribution channel; repeat purchasers.
- Proprietary Advantage.
Defendable intellectual property or market position; competitive barriers high enough to build significant equity value if the product or service proves successful in the market.
- Business Model.
Recurring revenue stream; High gross margins and operating leverage; attractive cash cycle; limited asset intensity.
- Deal Structure.
Fair and simple; aligned incentive among investor and management; efficient use of equity capital; attractive risk-return ratio.
- Exit Strategy.
Well defined with multiple logical acquirers and preferably IPO potential.